Join a C. Diff Vaccine Research Study
Now enrolling healthy adults aged 65+ for a C. Diff Vaccine Research Study in St. Louis, MO
See If You Qualify
Thank you for your interest in our clinical research study. To see if you may qualify, please answer a few brief questions about your health history. Your responses will only be used to evaluate eligibility. Participation is voluntary, and you can stop at any time.
- No cost to check eligibility
- No obligation to participate
- A coordinator confirms eligibility by phone
- You can withdraw at any time
This pre-screening does not guarantee enrollment.
Overview
We are currently enrolling participants for a C. Diff Vaccine research study. Researchers are evaluating a new vaccine that may help prevent C. difficile infection.
Your participation is a vital step toward expanding medical knowledge and protecting others for years to come.
Why You Should Join
By taking part in this clinical trial, you may reduce your risk of getting a C. diff infection while helping to advance research for a potential vaccine that could benefit others in the future.
About the Study
This research study will help us learn if an investigational vaccine is safe and can help prevent C. diff infection in people [65] years of age or older.
C. difficile infection (CDI) isn’t just uncomfortable—it often comes back, which can be stressful and hard to manage. We are inviting volunteers to take part in a research study testing a new vaccine that may help prevent this infection.
By joining, you are not just a participant; you are a partner in developing new treatments. Qualified participants may receive compensation for study-related time and travel.
C. diff risk factors
C. diff can affect anyone, but certain factors increase your risk: *Recent antibiotic use *Hospitalization or frequent visits to healthcare facilities *Age: People over the age of 65 are 10 times more likely to get a C. diff infection *Being immunocompromised: Medical conditions or treatments that weaken your immune system can increase your risk of infection. *Previous infection: While most people recover after treatment, about 1 in 9 people will get another C. diff infection within 8 weeks.
Benefits
Study-Related Care
Study-related tests, medication, and care provided at no cost
Compensation
Compensation of up to $1620 is available for study-related site visits and e-Diary completions. More available for other study-related activities.
Who Can Join
This clinical trial may be an option if you have not previously had C. diff and have one of the risk factors for infection.
You must be 65 years old or older.
You must have taken antibiotics within the last 3 months. (Antibiotics can sometimes increase the risk of getting C. difficile).
You were admitted to the hospital at least once in the last year.
You went to the emergency room (ER) two or more times in the last year.
You had 10 or more visits to the doctor’s office, clinic, or other healthcare facility in the last year.
You are scheduled to go into the hospital soon.
You have a planned surgery coming up.
What to Expect
* Eligible participants may receive compensation for completing all required study-related activities.
Study Visits and Phone Calls
In the first 18 months, you will have at least 3 in-person visits and 3 phone calls. You will then have one annual visit until the study ends.
Health Monitoring
[You/your health] will be closely monitored for C. diff infection. If you have 3 or more episodes of diarrhea in 24 hours while you are in the study, you will need to provide a stool sample and will be asked to attend extra study visits.
Participating Locations
Know Someone Who Might Qualify?
Share this study with a friend or family member who may benefit.